Glaucoma Drug Co. Hit With Class Action After Trial Tanks
Glaucoma drug company Aerie Pharmaceuticals was slapped with a proposed class action Wednesday by investors who say the company misled them into believing its lead drug would perform better in clinical...To view the full article, register now.
Already a subscriber? Click here to view full article